Open AccessEffectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis – a multicenter, randomized, investigator-masked, parallel group study in Chinese patients
Author(s) -
Tong Lin,
Lan Gong,
Sun,
Wei Chen,
Shao,
Guolan Gao,
Tang,
Yuan,
Zhao Zhao
Publication year - 2013
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s42624
Subject(s) - ganciclovir , medicine , keratitis , randomized controlled trial , visual acuity , ophthalmology , adverse effect , clinical trial , clinical endpoint , surgery , virus , virology , human cytomegalovirus
Parallel comparison with 0.15% ganciclovir (GCV) ophthalmic gel to evaluate the effectiveness and safety of 0.15% GCV in situ ophthalmic gel for the treatment of herpes simplex keratitis (HSK).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom